FICHe eHealth Accelerator Enters Final Phase with 20 Companies

FICHeThe FICHe eHealth accelerator has announced the 20 companies that will enter the third and final phase of the program. The final phase will be a 7-month mentorship period and each company will receive up to € 152.000 in working capital.

Timo Haikonen, chairman of the evaluation committee: "It has been most gratifying to monitor and witness the enthusiasm, innovation and dedication of the FICHe finalists. Every one of them deserves a credit for their hard work. May success follow them all."

Michel van Schaik, member of the evaluation committee adds: "The overall quality of all the participants was very good. Seeing all these innovations brought to the health sector in one place, proofs there is a lot of potential out there."

Paul Pelsmaeker, founder of the European FICHe accelerator: "We are all very excited about the outcome of the evaluation. All twenty selected companies have great potential in the market and that drives the FICHe team and coaches to help them grow in the next 7 months."

The companies selected for the final phase of FICHe are:

  • Px Healthcare (Netherlands), patient experience optimizing oncology outcomes;
  • Panatomy (Germany), online smart imaging database;
  • NeticTECH (Poland), medVC, remote video/audio consultation tool;
  • Medbravo (Spain), finding treatment options based on clinical trial for cancer patients;
  • Clinical Graphics (Netherlands), cloud based service for detection of osteoarthritis;
  • Andiamo (United Kingdom), 3D body scans collaboration cloud platform;
  • Psico Smart Apps (Spain), virtual environments for the treatment of anxiety disorders;
  • Scyfer (Netherlands), deep learning platform to detect degenerative brain disease in 3D-MRI;
  • Betawerk (Netherlands), IncoSense Smart, smart care service that measures incontinence;
  • Tripmedic (Malta), multi-sided platform to match-make international patients to doctors;
  • Mind Myths (Ireland); online mindfulness platform;
  • OurPath (United Kingdom), 12-week online lifestyle programme to prevent T2D;
  • Oviva (Switzerland), remote personal dietitian platform;
  • PLUX (Portugal), biofeedback modules for Ara platform;
  • Inbiolab (Netherlands). hARMONIC, miniaturized respiratory monitor based on EMG;
  • Ideable Solutions (Spain), Kwido, multi-device platform for the care of people;
  • NeuroAtHome (Spain), gamified software platform to deliver physical and cognitive therapy;
  • HealthApp (Spain), mobile application for the treatment of eating disorders;
  • Umanick (Spain), biometric platform for patient identification with HIS/EMR integration;
  • MySphera (Spain), tools to offer full transparency of healthcare processes in hospitals.

The twenty companies will be mentored and coached through an intense 7-month period led by the three ecosystems (Amsterdam, Murcia and Oulu) that are part of the project consortium.

The FICHe accelerator program will conclude with a demo day in 2016 where all companies will present to investors.

Related news articles:

About FICHe
FICHe provides companies with the overall funding of EUR 6.24 million for developing eHealth applications and creating sustainable business models. Funding will be distributed through a three-step process. In the first stage, companies will receive 15 000 euro for business model development. In the next phase, 40 out of the 80 companies will receive 50 000 euro for proof-of-concept. The third phase entering 20 out of the 40 companies will receive additionally 152 000 euro for working prototype development. At best, companies are therefore offered up to 217 000 euros funding.

FICHe is co-funded under the European Union's Programme for research, technological development and demonstration. Project partners are University of Oulu, Business Oulu, TIC BioMed, FFIS de la region de Murcia, TNO, Amsterdam Economic Board, Stichting zorgInc., Dutch eHealth Fund Management BV and Stichting Digitalezorg.nl.

About FIWARE technology
FIWARE is an innovative, open cloud-based infrastructure for cost-effective creation and delivery of Future Internet applications and services, at a scale not seen before. FIWARE API specifications are public and royalty-free, driven by the development of an open source reference implementation which accelerates the availability of commercial products and services based on FIWARE technologies.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...